For US Healthcare Professionals Only

Currently Viewing: 

Adult
Pediatric
Sotalol IV - sotalol hydrochloride injection 10 mL vial (15 mg/mL) logo

Currently Viewing: 

Adult
Pediatric

For US Healthcare Professionals

Contact Us

Contact us

Our team across the country is ready to help you. Send us a message below and your local representative will be in touch.

Have a scientific, clinical, or medical inquiry? Click here to send us a message →

Learn more about AltaThera Pharmaceuticals by exploring our corporate site →

  • Medical Information
  • Product Information
  • Report an Adverse Event
This website is intended for US healthcare professionals only.

By selecting an option below, you certify that you are a licensed US healthcare professional and wish to view information regarding Sotalol IV (sotalol hydrochloride injection). 

I’m using Sotalol IV in…

Adult Patients

View adult website

Pediatric Patients

View pediatric website

I am not a US healthcare professional

Leave website

Highlights of Prescribing Information

Boxed Warning, Indications, and Important Safety Information

Hide
Expand
WARNING: LIFE THREATENING PROARRHYTHMIA

Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation. To minimize the risk of drug induced arrhythmia, initiate or uptitrate intravenous sotalol in a facility that can provide continuous electrocardiographic monitoring and cardiac resuscitation [see Dosage and Administration (2.3) and Warnings and Precautions (5.1)].
Do not initiate intravenous sotalol therapy if the baseline QTc is longer than 450 ms. If the QTc prolongs to 500 ms or greater, reduce the dose or discontinue.